GATA6 was remarkably reduced in squamous cell lung carcinoma tissues and can inhibit the proliferation and migration of squamous cell lung carcinoma cells by transcriptionally restraining the expression of Shh, which imply that targeting GATA6 may be a potential therapy approach for squamous cell lung carcinoma 11. This evidence concerns the gene SHH and squamous cell lung carcinoma.